Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 16, 2014

View Archived Issues

Potency of a novel NRTI against drug-resistant retroviruses

Phase III clinical data for DTaP5-IPV-Hib-HepB vaccine in infants

GW Pharmaceuticals provides new physician reports of Epidiolex

Capricor Therapeutics acquires rights to family of natriuretic peptides

DKFZ to evaluate Imaxio's pro-immunogenic technology in HPV vaccine

Johnson & Johnson reports on active third quarter 2014

NanoLogix configuring N-Assay Rapid diagnostic kits for viruses

Idera's IMO-9200 moves into phase I development

Compound derived from traditional Chinese medicine has antipsoriatic activity

Purdue Pharma patents novel Nav1.7 blockers for pain

New BUB1 inhibitors disclosed by Bayer Schering Pharma for cancer

Researchers at Aptose Biosciences patent new agents for cancer

Beta cell-specific insulin gene knockout model reveals pancreatic cell fate in diabetes

Actinobac Biomed receives second NIH grant to support development of Leukothera

Novel Nav1.7 blockers divulged by Genentech and Xenon Pharmaceuticals

Advaxis reports preliminary data from phase I/II trial of ADXS-HPV in anal cancer

ActoGeniX reports data from phase I study of AG-014

FDA approves two idiopathic pulmonary fibrosis drugs ahead of schedule

Hanmi Pharmaceuticals and Kinex Pharmaceuticals report data from phase I Oratecan study

Alexion submits NDA in Japan for asfotase alfa

Retrophin to divest non-core assets to Turing Pharmaceuticals

FDA clears Lyra Parainfluenza Assay for use

FDA issues refusal to file letter in response to Insys' NDA for dronabinol

FDA grants priority review for lenvatinib in thyroid cancer

Nivolumab and ipilimumab combination receives FDA orphan drug designation

Compstatin 40 given U.S. orphan drug status for paroxysmal nocturnal hemoglobinuria

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...